Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial.
Ann Intern Med. 2024 Apr;177(4):449-457. doi: 10.7326/M23-2540. Epub 2024 Apr 2.
Ann Intern Med. 2024.
PMID: 38560901
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study.
Sverrisdottir I, Thorsteinsdottir S, Rognvaldsson S, Aspelund T, Vidarsson B, Onundarson PT, Agnarsson BA, Sigurdardottir M, Thorsteinsdóttir I, Sveinsdottir SV, Palmason R, Olafsson I, Sigurdsson F, Thordardóttir AR, Eythorsson E, Jonsson A, Palsson R, Indridason OS, Gislason GK, Olafsson A, Sigurdsson J, Steingrímsdóttir H, Einarsson Long T, Hultcrantz M, Durie BGM, Harding S, Landgren O, Kristinsson SY, Love TJ.
Sverrisdottir I, et al. Among authors: sveinsdottir sv.
Ann Intern Med. 2024 May 21. doi: 10.7326/M23-2867. Online ahead of print.
Ann Intern Med. 2024.
PMID: 38768457
Item in Clipboard
Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018.
Kristjánsson VB, Lund SH, Gröndal G, Sveinsdóttir SV, Agnarsson HR, Jónasson JG, Björnsson ES.
Kristjánsson VB, et al. Among authors: sveinsdottir sv.
Scand J Gastroenterol. 2021 Jan;56(1):46-52. doi: 10.1080/00365521.2020.1854847. Epub 2020 Dec 5.
Scand J Gastroenterol. 2021.
PMID: 33280485
Item in Clipboard
Red blood cell utilization and transfusion triggers in patients diagnosed with chronic lymphocytic leukaemia in Iceland 2003-2016.
Thorvaldsson HH, Vidarsson B, Sveinsdottir SV, Olafsson GB, Halldorsdottir AM.
Thorvaldsson HH, et al. Among authors: sveinsdottir sv.
Vox Sang. 2019 Jul;114(5):495-504. doi: 10.1111/vox.12775. Epub 2019 Mar 29.
Vox Sang. 2019.
PMID: 30972770
Item in Clipboard
Inflammatory plasma markers and risk for venous thromboembolism.
Sveinsdottir SV, Svensson PJ, Engström G.
Sveinsdottir SV, et al.
J Thromb Thrombolysis. 2014;38(2):190-5. doi: 10.1007/s11239-013-1033-6.
J Thromb Thrombolysis. 2014.
PMID: 24307292
Item in Clipboard
Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation.
Saemundsson Y, Sveinsdottir SV, Svantesson H, Svensson PJ.
Saemundsson Y, et al. Among authors: sveinsdottir sv.
J Thromb Thrombolysis. 2013 Oct;36(3):324-31. doi: 10.1007/s11239-012-0824-5.
J Thromb Thrombolysis. 2013.
PMID: 23054468
Clinical Trial.
Item in Clipboard
Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.
Sveinsdottir SV, Saemundsson Y, Isma N, Gottsäter A, Svensson PJ.
Sveinsdottir SV, et al.
Thromb Res. 2012 Sep;130(3):467-71. doi: 10.1016/j.thromres.2012.03.020. Epub 2012 Apr 17.
Thromb Res. 2012.
PMID: 22512897
Item in Clipboard
[Von Willebrand disease--from biochemistry to clinical practice].
Sveinsdottir SV, Hillarp A, Astermark J, Svensson PJ, Berntorp E.
Sveinsdottir SV, et al.
Lakartidningen. 2010 Aug 25-31;107(34):1923-7.
Lakartidningen. 2010.
PMID: 20960954
Review.
Swedish.
No abstract available.
Item in Clipboard
Cite
Cite